Consumer · Tobacco
Philip Morris International Inc.
$198.46 +2.11 (+1.07%) Pre-market $198.49 (+1.09%) ≈ ₹18,626 a share
Key numbers
- Market value
- $309.33B
- P/E (TTM)
- 29.0
- Forward P/E
- 23.4
- EPS (TTM)
- $6.85
- Dividend yield
- 3.22%
- Beta
- 0.35
- Day range
- $196.93 – $199.70
- 52-week range
- $146.35 – $214.35
- Volume
- 531,626
- 10-day avg volume
- $5.36M
- Revenue (TTM)
- $43.14B
- EBITDA (TTM)
- $18.83B
- Gross margin
- 67.7%
- Net margin
- 28.8%
- Return on equity
- —
- Debt / equity
- -599.2%
- Price / sales
- 7.17
- Shares out
- 1.56B
Quarterly results
Results for each quarter
Last 12 quarters from 10-Q and 10-K filings with the US SEC. Q4 = full year minus the first three quarters. Hover a bar to see the number.
Revenue and net income
Revenue · QoQ (vs last quarter)
Revenue · YoY (vs a year ago)
Net income · QoQ (vs last quarter)
Net income · YoY (vs a year ago)
| US$ | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.05B | $8.79B | $9.47B | $9.91B | $9.71B | $9.30B | $10.14B | $10.85B | $10.36B | $10.15B | $11.19B | $11.44B |
| Cost of revenue | $3.46B | $3.20B | $3.35B | $3.37B | $3.42B | $3.03B | $3.27B | $3.48B | $3.58B | $3.24B | $3.53B | $3.58B |
| Gross profit | $5.59B | $5.60B | $6.12B | $6.55B | $6.28B | $6.27B | $6.87B | $7.36B | $6.79B | $6.91B | $7.66B | $7.85B |
| Gross margin | 61.7% | 63.7% | 64.7% | 66.0% | 64.7% | 67.4% | 67.7% | 67.9% | 65.5% | 68.1% | 68.4% | 68.7% |
| Operating income | $2.89B | $3.05B | $3.44B | $3.65B | $3.26B | $3.54B | $3.71B | $4.26B | $3.37B | $3.89B | $4.53B | $4.87B |
| Operating margin | 31.9% | 34.6% | 36.4% | 36.9% | 33.6% | 38.1% | 36.6% | 39.3% | 32.6% | 38.4% | 40.5% | 42.5% |
| Pre-tax income | $2.61B | $2.73B | $3.10B | $3.45B | $2.92B | $3.29B | $3.42B | $4.02B | $3.15B | $3.66B | $4.29B | $4.59B |
| Income tax | $320.00M | $676.00M | $734.00M | $735.00M | $872.00M | $659.00M | $652.00M | $751.00M | $675.00M | $676.00M | $955.00M | $986.00M |
| Net income | $2.20B | $2.15B | $2.41B | $3.08B | $-579.00M | $2.69B | $3.04B | $3.48B | $2.14B | $2.44B | $2.82B | $3.31B |
| Net margin | 24.3% | 24.4% | 25.4% | 31.1% | -6.0% | 28.9% | 30.0% | 32.1% | 20.7% | 24.0% | 25.2% | 29.0% |
| EPS (diluted) | — | $1.38 | $1.54 | $1.97 | — | $1.72 | $1.95 | $2.23 | — | $1.56 | $1.80 | $2.12 |
Income statement
Results for each year
8 fiscal years from the company's 10-K filings with the US SEC.
Revenue, gross profit and net income
Revenue · YoY (vs a year ago)
Net income · YoY (vs a year ago)
EPS (diluted) · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.63B | $29.81B | $28.69B | $31.41B | $31.76B | $35.17B | $37.88B | $40.65B |
| Revenue growth | — | 0.6% | -3.7% | 9.4% | 1.1% | 10.7% | 7.7% | 7.3% |
| Cost of revenue | $10.76B | $10.51B | $9.57B | $10.03B | $11.40B | $12.89B | $13.33B | $13.37B |
| Gross profit | $18.87B | $19.29B | $19.13B | $21.38B | $20.36B | $22.28B | $24.55B | $27.28B |
| Gross margin | 63.7% | 64.7% | 66.7% | 68.1% | 64.1% | 63.3% | 64.8% | 67.1% |
| Research & development | $383.00M | $465.00M | $495.00M | $617.00M | $642.00M | $709.00M | $759.00M | $756.00M |
| Operating income | $11.38B | $10.53B | $11.67B | $12.98B | $12.25B | $11.56B | $13.40B | $14.89B |
| Operating margin | 38.4% | 35.3% | 40.7% | 41.3% | 38.6% | 32.9% | 35.4% | 36.6% |
| Depreciation & amortisation | $989.00M | $964.00M | $981.00M | $998.00M | $1.08B | $1.40B | $1.79B | $2.00B |
| Interest expense | $855.00M | $796.00M | $728.00M | $737.00M | $768.00M | $1.53B | $1.76B | $1.59B |
| Pre-tax income | $10.67B | $9.87B | $10.95B | $12.23B | $11.63B | $10.45B | $12.20B | $13.88B |
| Income tax | $2.45B | $2.29B | $2.38B | $2.67B | $2.24B | $2.34B | $3.02B | $2.74B |
| Tax rate | 22.9% | 23.2% | 21.7% | 21.8% | 19.3% | 22.4% | 24.7% | 19.7% |
| Net income | $7.91B | $7.19B | $8.06B | $9.11B | $9.05B | $7.81B | $7.06B | $11.35B |
| Net margin | 26.7% | 24.1% | 28.1% | 29.0% | 28.5% | 22.2% | 18.6% | 27.9% |
| EPS (diluted) | $5.08 | $4.61 | $5.16 | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 |
Balance sheet
Assets and debt
At each fiscal year end.
Equity, debt and cash
Shareholders' equity · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.59B | $6.86B | $7.28B | $4.50B | $3.21B | $3.06B | $4.22B | $4.87B |
| Current assets | $19.44B | $20.51B | $21.49B | $17.72B | $19.62B | $19.76B | $20.17B | $24.36B |
| Total assets | $39.80B | $42.88B | $44.82B | $41.29B | $61.68B | $65.30B | $61.78B | $69.19B |
| Current liabilities | $17.19B | $18.83B | $19.62B | $19.26B | $27.34B | $26.38B | $22.92B | $25.43B |
| Total liabilities | $50.54B | $52.47B | $55.45B | $49.50B | $67.99B | $74.75B | $71.65B | $77.21B |
| Shareholders' equity | $-12.46B | $-11.58B | $-12.57B | $-10.11B | $-8.96B | $-11.23B | $-11.75B | $-9.99B |
| Current ratio | 1.13 | 1.09 | 1.10 | 0.92 | 0.72 | 0.75 | 0.88 | 0.96 |
Cash flow
Cash coming in and going out
Free cash flow = cash from operations minus capital spending. Shareholder returns = dividends + buybacks.
Free cash flow and shareholder returns
Operating cash flow · YoY (vs a year ago)
Free cash flow · YoY (vs a year ago)
| US$ | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | $9.48B | $10.09B | $9.81B | $11.97B | $10.80B | $9.20B | $12.22B | $12.23B |
| Capital spending | $-1.44B | $-852.00M | $-602.00M | $-748.00M | $-1.08B | $-1.32B | $-1.44B | $-1.57B |
| Free cash flow | $8.04B | $9.24B | $9.21B | $11.22B | $9.73B | $7.88B | $10.77B | $10.66B |
| FCF margin | 27.1% | 31.0% | 32.1% | 35.7% | 30.6% | 22.4% | 28.4% | 26.2% |
| Cash from investing | $-998.00M | $-1.81B | $-1.15B | $-2.36B | $-15.68B | $-3.60B | $-1.09B | $-3.97B |
| Cash from financing | $-9.65B | $-8.06B | $-8.50B | $-11.98B | $3.81B | $-5.58B | $-9.48B | $-8.13B |
| Dividends paid | $-6.89B | $-7.16B | $-7.36B | $-7.58B | $-7.81B | $-7.96B | $-8.20B | $-8.62B |
| Share buybacks | — | $0 | $0 | $-775.00M | $-209.00M | $0 | $0 | — |
About
About Philip Morris International Inc.
Philip Morris International Inc. (PMI) is a American publicly traded tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 117 in the 2025 Fortune 500 list of the largest US corporations by total revenue.
From Wikipedia (CC BY-SA 4.0).
Company details
- Company name
- Philip Morris International Inc.
- Ticker
- PM
- Exchange
- NYSE
- ISIN
- US7181721090
- SEC CIK
- 0001413329
- Sector
- Consumer
- Industry
- Tobacco
- SEC industry (SIC)
- Cigarettes (2111)
- Incorporated in
- Virginia
- Financial year ends
- 31 December
- Filer type
- Large accelerated filer
- Latest annual report (10-K)
- 6 Feb 2026
- CEO
- Jacek Olczak
- Chair
- André Calantzopoulos
- Headquarters
- Lausanne
- Address
- 677 Washington Blvd, Ste. 1100, Stamford, Ct 06901
- Founded
- 2008
- Employees
- 84,900
- Trades in
- US dollars (USD)
- Website
- pmi.com
News
Latest news
From Google News; each link opens the publisher's story.
Peers
Others in Consumer
Quotes from CNBC (may be delayed), financials from SEC EDGAR, profile from global-stock-logos (MIT). Information only, not investment advice.